EQT Logo
Current Portfolio

MinervaX

MinervaX is a biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus.

Key Facts
Sector

Life Sciences

Country

Denmark

Fund

LSP 7

Entry

2023

Website

Minervax

Do You Want to Know More?

We are eager to explore how we can achieve great things together.